Vimarsana
Biggest News Aggregation in the World

Allergic Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allergic Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allergic Inflammation Today - Breaking & Trending Today

Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting - Vimarsana News

Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting

-- AYVAKIT data in patients with indolent systemic mastocytosis show durable efficacy and favorable safety supporting long-term treatment, consistent with...

Mass General Brigham Awards $1 Million to Biotech - Vimarsana News

Mass General Brigham Awards $1 Million to Biotech

Game-changing biotech innovations include new delivery system for brain cancer therapeutics, better detection of potential pregnancy complications,...

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltristrade; Nasal Spray in Singapore, Hong Kong and Vietnam - Vimarsana News

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltristrade; Nasal Spray in Singapore, Hong Kong and Vietnam

Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltris Nasal Spray in Singapore, Hong Kong and Vietnam - Vimarsana News

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltris Nasal Spray in Singapore, Hong Kong and Vietnam

Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltristrade; Nasal Spray in Singapore, Hong Kong and Vietnam - Vimarsana News

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclusive licensing agreement for commercializing Ryaltristrade; Nasal Spray in Singapore, Hong Kong and Vietnam

Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark S